D8 Holdings Corp. (NASDAQ: DEH) stock gained by 7.47% in the after-hours trading. D8 Holdings Corp. is a distinctive acquisition firm looking to partner with a business that uses technology and creativity to disrupt huge addressable industries. D8’s goal is to find a target company that is undervalued in comparison to its potential and is ready for a transformation.
According to a source familiar with the situation, Vicarious Surgical, a developer of medical robot technology sponsored by Microsoft co-founder Bill Gates, is in discussions to go public through a merger with blank check business D8 Holdings Corp.
According to the individual, the firms are contemplating a transaction that would value the combined entity at around $1.1 billion. The negotiations are confidential, so the person did not want to be identified. The terms aren’t set in stone, and it’s possible that negotiations will break down.
DEH has reported that they have reached an agreement on a final business combination. The merged business will operate as Vicarious Surgical Inc. and will be traded on the New York Stock Exchange under the new ticker code “RBOT” after the deal is completed.
Vicarious Surgical is a next-generation robotics business that is creating a game-changing technology with the objective of enhancing surgical process efficiency, improve quality of care, and lowering healthcare costs.
Adam Sachs, Co-Founder & CEO of Vicarious Surgical said,
Vicarious Surgical is ecstatic to introduce their collaboration with Donald Tang, David Chu, and the rest of the D8 team, which they feel will help them boost the pace of their flagship robot and provide the groundwork for long-term success. Mr. Tang and the D8 team recognize the potential of their technology to make treatments safer and more accessible to patients while also saving hospitals money and time. They are excited to reach the public markets with the D8 team by their side.
Brodsky & Smith, LLC declared that it is conducting an investigation for the potential claims toward D8 Holdings Corp’s Board of Directors for potential infringements of fiduciary duty and other breaches of federal and state law in link with a merger agreement under which D8 Holdings will merge with Vicarious Surgical Inc., resulting in Vicarious becoming a publicly-traded company. D8 Holdings stockholders will possess just 22.3 percent of the merged firm under the terms of the deal.
The inquiry is looking into whether the D8 Holdings Board of Directors violated its fiduciary obligations to shareholders by failing to execute a fair process, which included diluting ownership interests in the merged firm.